Elagolix for endometriosis: all that glitters is not gold
Sign Up to like & getrecommendations! Published in 2019 at "Human Reproduction"
DOI: 10.1093/humrep/dey368
Abstract: Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis. As the degree of ovarian suppression obtained with… read more here.
Keywords: endometriosis glitters; endometriosis; elagolix; drug ... See more keywords